Authors
Amgad Elshikh, Lashin S Ali, Mohammed S ElSharkawy, Sameh M Fathy, Bahaa G Mohamed, Khaled Hamama, Mahmoud A Elmohasseb, Eman H Abu Shanab, Zainab T Ragab, Saad A Moharam, Ahmed F Mady
Published in
BMC anesthesiology. Volume 26. Issue 1. Jul 07, 2026. Epub Jul 07, 2026.
Abstract
Nephrectomy procedures result in considerable postoperative discomfort, and limitations on the use of traditional management include opioid-related adverse effects and epidural-associated side effects. A prospective comparison was conducted to evaluate the relative effectiveness of two regional anesthetic techniques, the external oblique intercostal plane block (EOIPB) and the ultrasound-guided posterior transversus abdominis plane block (TAPB), in reducing postsurgical pain after open nephrectomy (OPN).
Forty adults who underwent elective OPN were included in the study. The study population was randomly divided into two groups to receive either EOIPB or TAPB in a volume of 20 mL with 0.5% bupivacaine after the induction phase. The primary outcome was cumulative 24-hour pethidine consumption. Secondary outcomes included intraoperative fentanyl requirements, time to first rescue analgesia, pain scores at 0, 4, 8, 12, 18, and 24 h postoperatively, hemodynamic parameters, adverse events, and patient satisfaction.
The EOIPB group had significantly lower pain scores at 4, 8, 12, and 18 h after surgery compared to the TAPB group (p < 0.05). The EOIPB group used significantly less pethidine than the other group (61.5 ± 24.77 mg vs. 114 ± 12.31 mg, p < 0.001), and it took them longer to receive their first rescue analgesia (7.25 ± 0.91 vs. 6.1 ± 1.55 h, p = 0.007). The EOIPB group exhibited significantly higher patient satisfaction (p = 0.045), although the two groups had similar profiles of adverse events.
In adults undergoing OPN, EOIPB provided superior early postoperative analgesia compared to TAPB during the first 18 h after surgery, as evidenced by lower pain scores, reduced opioid requirements, delayed time first to rescue analgesia, and higher patient satisfaction. Both blocks demonstrated comparable safety profiles.
Registration occurring at ClinicalTrials.gov (ID: NCT06452238), (URL: https://clinicaltrials.gov/study/NCT06452238?cond=NCT06452238&rank=1 ), Date: (30-5-2024).
PMID:
42410497
Bibliographic data and abstract were imported from PubMed on 07 Jul 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 9
- Comments 0